Assessment of the utility of MAIT cells as a biomarker for inflammatory bowel diseases
Not Applicable
Completed
- Conditions
- Inflammatory bowel diseases
- Registration Number
- JPRN-UMIN000013847
- Lead Sponsor
- Juntendo University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1.Severe complecations. 2.Have other autoimmune disorders. 3.Using antithrombotic drugs. 4.Pregnant woman. 5.Judged to be inappropriate to the study.
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What is the role of MAIT cells in the pathogenesis of Crohn's disease and ulcerative colitis?
How do MAIT cell biomarkers compare to traditional IBD markers like calprotectin and CRP in diagnostic accuracy?
What are the potential therapeutic targets modulating MAIT cell activity in inflammatory bowel diseases?
Are there specific cytokine profiles associated with MAIT cell dysfunction in IBD patients?
What is the relationship between MAIT cell frequency and disease severity in IBD subtypes?